Antiretroviral drug resistance and routine therapy, Cameroon

被引：25

作者：

Laurent, C ^{[1
]}

Kouanfack, C

Vergne, L

Tardy, M

Zekeng, L

Noumsi, N

Butel, C

Bourgeois, A

Mpoudi-Ngolé, E

Koulla-Shiro, S

Peeters, M

Delaporte, E

机构：

[1] Inst Rech Dev, UMR 145, Montpellier, France

[2] Cent Hosp, Yaounde, Cameroon

[3] Lab Sante Hyg Mobile, Yaounde, Cameroon

[4] Natl AIDS Program, Yaounde, Cameroon

[5] Mil Hosp, Yaounde, Cameroon

来源：

EMERGING INFECTIOUS DISEASES | 2006年 / 12卷 / 06期

关键词：

D O I：

10.3201/eid1206.050860

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 16.4% had drug resistance after a median of 10 months. Of these, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 10.2% to non-NRTIs, and 2.3% to protease inhibitors.

引用

页码：1001 / 1004

页数：4

共 50 条

[31] Prevalence and predictors of triple-class antiretroviral drug resistance in routine HIV primary care
Napravnik, S.
Keys, J.
Quinlivan, E. B.
Wohl, D. A.
Myers, A. M.
Eron, J. J., Jr.
ANTIVIRAL THERAPY, 2006, 11 (05) : S88 - S88
[32] Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda
Kaleebu, Pontiano
Kirungi, Wilford
Watera, Christine
Asio, Juliet
Lyagoba, Fred
Lutalo, Tom
Kapaata, Anne A.
Nanyonga, Faith
Parry, Chris M.
Magambo, Brian
Nazziwa, Jamirah
Nannyonjo, Maria
Hughes, Peter
Hladik, Wolfgang
Ruberantwari, Anthony
Namuwenge, Norah
Musinguzi, Joshua
Downing, Robert
Katongole-Mbidde, Edward
PLOS ONE, 2015, 10 (12):
[33] Antiretroviral therapy for children in the routine setting in Malawi
Bell, F.
Bong, C. N.
Bramson, B.
Ellis, J.
Fitzgerald, M.
Goossens, S.
Graham, S. M.
Harries, A. D.
Hochgesang, M.
Jobarteh, K.
Kamthunzi, P.
Kazembe, R.
Libamba, E.
Makombe, S.
Massaquoi, M.
Mhango, E.
Molyneux, E. M.
Mwansambo, C.
Nyang'wa, B.-T.
Pasulani, O.
Phiri, S.
Poerksen, G.
Schouten, E. J.
Torjesen, K.
van Oosterhout, J. J. G.
Weigel, R.
Yu, J.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2007, 101 (05) : 511 - 516
[34] Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling
Billong, Serge Clotaire
Fokam, Joseph
Penda, Calixte Ida
Amadou, Salmon
Kob, David Same
Billong, Edson-Joan
Colizzi, Vittorio
Ndjolo, Alexis
Bisseck, Anne-Cecile Zoung-Kani
Elat, Jean-Bosco Nfetam
BMC INFECTIOUS DISEASES, 2016, 16
[35] Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling
Serge Clotaire Billong
Joseph Fokam
Calixte Ida Penda
Salmon Amadou
David Same Kob
Edson-Joan Billong
Vittorio Colizzi
Alexis Ndjolo
Anne-Cecile Zoung-Kani Bisseck
Jean-Bosco Nfetam Elat
BMC Infectious Diseases, 16
[36] Routine monitoring of antiretroviral therapy is not cost effective
Purslow, Caroline
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (03) : 257 - 257
[37] Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance
Weidle, PJ
Malamba, S
Mwebaze, R
Sozi, C
Rukundo, G
Downing, R
Hanson, D
Ochola, D
Mugyenyi, P
Mermin, J
Samb, B
Lackritz, E
LANCET, 2002, 360 (9326): : 34 - 40
[38] Antiretroviral therapy and drug interactions
Cohen, K
Andrews, S
Maartens, G
SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2001, 91 (10): : 816 - 819
[39] Antiretroviral therapy for drug users
Clarke, SM
Mulcahy, FM
INTERNATIONAL JOURNAL OF STD & AIDS, 2000, 11 (10) : 627 - 631
[40] Benefits and Limits of Antiretroviral Drug Monitoring in Routine Practice
Maitre, Thomas
Muret, Patrice
Blot, Mathieu
Waldner, Anne
Duong, Michel
SI-Mohammed, Ali
Chavanet, Pascal
Aho, Serge
Piroth, Lionel
CURRENT HIV RESEARCH, 2019, 17 (03) : 190 - 197

← 1 2 3 4 5 →